Human Milk
15
2
2
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.3%
2 terminated out of 15 trials
77.8%
-8.7% vs benchmark
7%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Developing Remote Human Milk Collection as a Novel Technique for Transcriptome Sequencing
UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk
Assessing Exclusive Breastfeeding Practice
Noninferiority Trial of Liquid Human Milk Fortifier (HMF) Hydrolyzed Protein Versus Liquid HMF With Supplemental Liquid Protein
Targeted Breast Milk Fortification for Very Low Birth Weight Infants in the NICU
Comparison of Breast Milk Content in Mothers Using a Expressing Pump and Milking by Hand
The Effect of Covid-19 on Breast Milk Microbiome and Its Bioactive Components
Responsive Feeding of Infants With Expressed Milk
Effect of Tube Feeding on LCPUFAs Delivery
Growth and Weight Gain in ELBW Infants Fed an Exclusively Human Milk Based Diet With Prolacta®
Human Milk Lipid Profile Assessment and Influences of Mother's Diet
Protein Balance and Body Composition in Preterm Infants
Human Milk Fortification in Very Low Birth Neonates
Efficacy of Breast Milk Expressed and Sucrose in Procedural Pain in Preterm
The Influence of Storage Container and Defrost Process on Components in Breast Milk